alexa
Reach Us +1-218-451-2974
Nanotechnology In Head And Neck Cancer | 12421
ISSN: 2161-119X

Otolaryngology: Open Access
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences

Worldwide Forum on Otolaryngology and ENT Surgery

Barcelona, Spain

6th European Otolaryngology-ENT Surgery Conference

Vienna, Austria
Share This Page

Nanotechnology in head and neck cancer

International Conference and Exhibition on Otolaryngology

Ivan H El-Sayed

ScientificTracks Abstracts: Otolaryngology

DOI: 10.4172/2161-119X.S1.002

Abstract
Head and neck cancers represent 2-6% of all cancers in the United States and are aggressive neoplasms that can be resistant to current treatments. Treatment of tumors can be cosmetically and functionally disfiguring and tumors can still recur or spread to regional lymph nodes or distant organs. Novel technologies are necessary to overcome this disease. Nanotechnology represents a novel technology with the potential to revolutionalize medicine with a range of diagnostic applications and treatments. At the size range of less than 200nm, nanoparticles can demonstrate new physical properties unlike their bulk material. For instance some nanoparticles serve as ultrabright beacons over 1 million times brighter than current probes. Extensive research is currently underway to evaluate nanoparticles as diagnostic probes, drug and gene carriers, electro/magnetic/photothermal therapy agents and even as radiation enhancers. This talk will review potential medical innovations using the our lab�s work with gold nanoparticles as an example.
Biography

Dr. El-Sayed completed his Otolaryngology training at Boston University and a Head and Neck Surgical Oncology fellowship at the University of California San Francisco in 2003. He is currently the Co-Director of the Center of Minimally Invasive Skull Base Surgery at UCSF and focuses on management of tumors of the paranasal sinuses, skull base, salivary glands and infratemporal fossa. His research interests are endoscopic skull base surgery and also nanotechnology in head and neck cancer as the Director of the Head and Neck Nanomedicine Laboratory. His team has put on an annual course ?Surgical Approaches to the Skull Base? for neurosurgical and otolaryngology residents for the past 3 years. Dr. El-Sayed has authored nearly 50 journal articles or book chapters, including the number 1 cited article in the field of chemistry in 2007. He is serving or has served on the editorial boards of the World Journal of Oncology, Journal of Nanomedicine & Nanotechnology, Otolaryngology-Omics Group, ISRN Nanotechnology- Hindawi, and the World Journal of Otolaryngology, and the Open Otorhinolaryngology Journal.

Top